Health

Please join us for a conversation with President and CEO of CARE USA Helene D. Gayle and Ford School faculty Marina Whitman and Sharon Maccini on current trends in international development aid, microfinance, and global health initiatives.

How is it possible that the United States, which spends more than any other nation on health care and insurance, now has a population markedly less healthy than those of many other nations? Sociologist and public health expert James S. House calls for a complete reorientation of how we think about health.

John Ayanian and Michael McWilliams, Harvard Medical School.

Universal child care has been a longstanding goal of child care advocates in both Canada and the United States since the 1960s, yet in 2016 that goal remains stubbornly elusive in both federations despite decades of activism. Responsibility for child care delivery has been shared in both countries between federal, “meso” (provincial/state), and local governments with more of that responsibility being downloaded to the state/provincial level since the 1990s. Dr. Collier will present two meso level cases (Ontario and Michigan) to understand how child care advocates have navigated these decentralized landscapes. What factors explain successful policy outcomes and what barriers persist? Are universal programs and longer term social justice advocacy claims viable in decentralized federations?  View the poster.

The Critical Race Theory (CRT) Discussion Series is co-sponsored by the Ford School and the University of Michigan Law School. Graduate and professional students are invited to join us for our first session, "A primer: Critical Race Theory and Public Policy." Lunch will be provided.

An illustrious group of Michigan graduates from fields such as economics, education, political science, psychology, public policy, social work, sociology, and women’s studies will discuss past, present, and future research on issues related to gender, race, poverty, inequality, and economic mobility.

Lecture by Angelina Godoy, Helen H. Jackson Chair inHuman Rights and Director, Center for Human Rights, University of Washington Abstract: In recent years, the application of intellectual property (IP) to pharmaceutical products has generated increasing controversy in many contexts around the world. Like other parts of Latin America, Central American countries were required to introduce reforms to their IP laws under the terms of the WTO's TRIPS Agreement, and later by the ratification of their trade agreement with the United States, which required yet stricter provisions.